American College of Clinical Pharmacy
      Search      Cart


NIH Publishes COVID-19 Treatment Guidelines Update on Anti-SARS-CoV-2 Monoclonal Antibodies

August 19, 2022

The COVID-19 Treatment Guidelines Panel has published an update to the Anti-SARS-CoV-2 Monoclonal Antibodies of the Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.

This update provides new information on the in vitro susceptibility of the circulating SARS-CoV-2 variants of concern to the available anti-SARS-CoV-2 monoclonal antibodies (mAbs). It also discusses the anticipated clinical activity of the different anti-SARS-CoV-2 mAbs against the Omicron BA.4 and BA.5 subvariants.

For more information on recent updates, please see What's New in the Guidelines on the COVID-19 Treatment Guidelines website.


This website uses cookies to help ACCP provide you with the best user experience. If you continue to use our services, ACCP will assume that you agree to the use of such cookies. You can find out how to update your settings by referring to ACCP’s Policy on Cookies.